Kate Fitzgerald, PhD
Research Focus - Leveraging Nucleic Acid Sensing Pathways for Cancer Immunotherapy
- Understanding inflammatory responses and colonic cancer
- Elucidating tumor DNA-driven responses
- Characterizing the cGAS (cyclic GMP-AMP synthase)-STING (stimulator of interferon genes) signaling pathway and anti-tumor immunity
Representative Publication
Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 2019;20(11):657-674.
In the News
Getting Results…
-
Read more
-
Robert W. Finberg Physician-Scientist Training Program launching at UMass Chan
Read more -
Katherine Fitzgerald, Phillip Zamore elected to American Academy of Arts & Sciences
Read more -
UMass Chan scientists deliver siRNA therapy to lung
Read more -
Nanobody treatment developed by MassBiologics shows promise for treating SARS-CoV-2 infection
Read more -
UMass Chan BRIDGE Fund supports seven faculty projects with commercialization potential
Read more -
Innate Immunity Day at UMass Chan will honor Robert Finberg
Read more -
UMass Center for Clinical and Translational Science awards seven new pilot grants
Read more -
Katherine Fitzgerald to receive American Association of Immunologists award
Read more -
Four interdisciplinary collaborations share mission to demystify devastating brain disorders
Read more -
UMMS research identifies potential antiviral compound for COVID-19, flu, other viral infection
Read more -
Katherine Fitzgerald and Nikolaus Grigorieff elected to National Academy of Sciences
Read more -
UMMS immunologist Katherine Fitzgerald admitted to Royal Irish Academy
Read more -
Katherine Fitzgerald and Sanjay Ram elected to American Academy of Microbiology
Read more